@IndigoC
It occurs to me that now that the U.K. is moving away from giving AZ to under 40s it would make sense for the U.K. AZ factory to start directing some of their capacity to Europe? Seems only fair given the Pfizer and Moderna we’re using is coming from Europe and once second doses are done we’ll have no use for the remaining 40-50 million doses in our contract.
The problem is that the UK has a population if roughly 21.5 million between the ages of 40-65. Some will still be waiting for first vaccines, most waiting for second.
You seem to forget it was shortages of Pfizer, AZ and recently Moderna that caused the UK to make the decision way back in January to increase it's timing between doses. The EU could have done the same to mitigate vaccines shortages but chooses not to.
Second doses of AZ in the UK won't be completed until mid-end of July. However, the EU lawsuit this week demands another 90 million doses by the end of July.
How many doses do you think the UK will not "have use for" by then? Where are these 90million doses to come from exactly?
Yes, the UK has contracts with Pfizer and Moderna, vaccines produced in the EU. But our contracts with these companies are irrelevant in the context of the EU's contracts with AZ. Surely if we're talking about fairness, then sending 5m doses of vaccine back to India should be top of the list?